tadalafil has been researched along with Dysplastic Nevus Syndrome, Hereditary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbasi, B; Breyer, BN; Hakam, N; Lui, JL; Shaw, NM | 1 |
| Argenziano, G; Brancaccio, G; Briatico, G; Capone, F; Cilio, S; Crocetto, F; Ferro, M; Imbimbo, C; Salonia, A | 1 |
1 review(s) available for tadalafil and Dysplastic Nevus Syndrome, Hereditary
| Article | Year |
|---|---|
The relationship between the history of PDE5-inhibitors assumption and melanoma: a systematic review.
Topics: Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Skin Neoplasms; Tadalafil; Vardenafil Dihydrochloride | 2023 |
1 other study(ies) available for tadalafil and Dysplastic Nevus Syndrome, Hereditary
| Article | Year |
|---|---|
Adverse reactions of PDE5 inhibitors: An analysis of the World Health Organization pharmacovigilance database.
Topics: Adolescent; Adult; Erectile Dysfunction; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Pharmacovigilance; Phosphodiesterase 5 Inhibitors; Priapism; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride; World Health Organization | 2023 |